CELEX: 62022TN0036
Language: en
Date: 2022-01-19 00:00:00
Title: Case T-36/22: Action brought on 19 January 2022 — Romedor Pharma v EUIPO — Perfect Care Distribution (PERFECT FARMA CERVIRON)

28.3.2022   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 138/23
            
         
      Action brought on 19 January 2022 — Romedor Pharma v EUIPO — Perfect Care Distribution (PERFECT FARMA CERVIRON)
      (Case T-36/22)
      (2022/C 138/27)
      Language in which the application was lodged: Romanian
      
         Parties
      
      
         Applicant: Romedor Pharma SRL (Focşani, Romania) (represented by: E. Dicu, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Perfect Care Distribution (Bucharest, Romania)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: EU figurative mark PERFECT FARMA CERVIRON — EU trade mark No 10 864 511
      
         Procedure before EUIPO: proceedings for a declaration of invalidity
      
         Contested decision: Decision of the Second Board of Appeal of EUIPO of 17 November 2021 in Case R 522/2021-2
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  uphold the action as formulated and reasoned;
               
            
                  —
               
               
                  annul the contested decision and, consequently, uphold the application for a declaration of invalidity in respect of EU trade mark No 10 864 511.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Article 60(1)(c), in conjunction with Article 8(4), of Regulation (EU) No 2017/1001 of the European Parliament and of the Council.